OMIX

Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) +Data of Genomic Targeting Analysis and Statistic

OMIX006358

1Summary
Title Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) +Data of Genomic Targeting Analysis and Statistic
Description Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) Data of Genomic Targeting Analysis and Statistics
Organism Homo sapiens
Data Type Other Type of Genomic Data
Data Accessibility Controlled-access
BioProject PRJCA017207
Release Date 2024-06-15
Submitter lin shen (linshenpku@163.com)
Organization Beijing Cancer Hospital
Submission Date 2024-05-06
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX006358-02 LB1001-201 Summary of genotype analysis of patient medical history 1 Other Type of Genomic Data 23.3 KB xlsx 0 Unavailable

Request for this Data View All Released Data of OMIX